Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer.
Clin Lung Cancer
; 20(3): 201-207, 2019 05.
Article
in En
| MEDLINE
| ID: mdl-30442524
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Drug-Related Side Effects and Adverse Reactions
/
Antineoplastic Agents, Immunological
/
Nivolumab
/
Immunotherapy
/
Lung Neoplasms
/
Antibodies, Monoclonal
Type of study:
Incidence_studies
/
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Lung Cancer
Journal subject:
NEOPLASIAS
Year:
2019
Document type:
Article
Affiliation country:
Francia
Country of publication:
Estados Unidos